Genetic Differences Affecting Immunotherapy Response

Register for the Webinar

Already registered?
Access the webinar here »

Immunotherapy holds great promise for cancer treatment, but why some patients respond better to immunotherapy than others remains a mystery. To uncover the role of genomic heterogeneity in therapeutic efficacy, scientists combine whole genome sequencing of patient samples with machine learning and animal models. In this webinar, Kuan-lin Huang and Benjamin Ostendorf will discuss recent research insights into the contributions of genomic heterogeneity to immunotherapy responses and outcomes.

Topics to be covered

  • Predicting tumor immune response using genomic markers and machine-learning
  • Determining melanoma progression and therapeutic response with common APOE germline variants

Speaker Information:

circle 1

Kuan-lin Huang, PhD
Assistant Professor
Department of Genetics and Genomic Sciences
Mount Sinai Center for Transformative Disease Modeling
Icahn School of Medicine at Mount Sinai

circle 2

Benjamin Ostendorf, MD, PhD
Max Eder Group Leader
Charité – Universitätsmedizin Berlin

Webinar Sponsors


cell signaling transparent logo


Thermo Fisher Logo